Head and Neck Forum - Free Communications 1

5:00 PM • HN 04-01 • Type-specific data on human papillomavirus infection in oropharyngeal squamous cell carcinoma in Europe > N. Nabi Kanibir 5:08 PM • HN 04-02 • A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell cancers in Germany > M. Miriam Reuschenbach 5:16 PM • HN 04-03 • Human papillomavirus in carcinomas of the sinonasal tract > S. S. James Brown 5:24 PM • HN 04-05 • Opportunistic oral HPV infections in HIV/AIDS: primary human three-dimensional tissue treated with HIV protease inhibitors is permissive to HPV16 infection and progeny virion biosynthesis > C. Craig Meyers 5:32 PM • HN 04-06 • The incidence of oral human papillomavirus infection within the healthy young adult UK population > A. Aimee Whitton 5:40 PM • HN 04-07 • Prevalence of oral and cervical human papillomavirus infections in women attending colposcopy clinics in Ireland > P. Prerna Tewari 5:48 PM • HN 04-08 • Prevalence of biologically active HPV infection in tumor-free oropharyngeal tissue of OPSCC-patients > V. Vittoria Guarda 5:56 PM • HN 04-10 • Vaccination in recurrent respiratory papillomatosis > M. Magdalena Chirila 6:04 PM • HN 04-11 • Correlation between survival rate and mortality and the presence of the HPV in patients with esophageal squamous cell carcinoma (ESCC) > L. Luiz Filipe Alkamin Woellner 6:12 PM • HN 04-12 • Oral cancer screening. Brush sampling and FTA cards for automated HR-HPV diagnosis and automated cytology analyses with AI of mucosal lesions > C. Christina Runow Stark 6:20 PM • HN 04-13 • Epidemiology of oropharyngeal cancer related to human papillomavirus in a classically low burden region > M. Marisa Mena 6:28 PM • HN 04-14 • Incidence trends in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma subsites in the United States and Canada, 1995-2015 > N. Nosayaba OSAZUWA-PETERS